A GLOBAL LIFE SCIENCE EVENT
Bridging the Gap is a life science event organized together by the Swedish American Chamber of Commerce in San Diego, San Francisco/Silicon Valley and New England - the top three life science clusters in the U.S. Since Life Science Bridge's mission is to promote trade between our clusters and Sweden, we are very excited to announce our second round of Bridging the Gap - a two-day event with the purpose to inspire, educate and connect people in the life science scene. With Sweden and the U.S. being at the top of the life science industry, we aimed to build bridges between these nations to promote a healthy and innovative world. To make the event even more global, this year’s edition of Bridging the Gap will be in partnership with the Finnish American Chamber of Commerce in San Diego.
Bridging the Gap 2022 will be a two-day webinar on April 20th-21st, with speakers within the various areas followed by a networking session on each day. Day 1 will have the theme Expanding to the U.S and day 2 will be focusing on The Future of Life Science.
The event will be free of charge and you can sign up for Bridging the Gap 2022 through the links below.
DAY 1: Expanding to the U.S.
Jack Florio, Managing Director at Weild & Co.
Jack will discuss various sources of funding available for life science companies in the U.S. as they move through their stages of development and the expectations of investors. More info on Jack can be found here.
Lars Oddsson, CTO and Co-Founder of RxFunctions, Inc.
Lars will explain how to bring a novel medical device to the U.S. market. More info on Lars can be found here.
Jonathan P. Gertler, Managing Partner and CEO at Back Bay Life Science Advisors
Dr. Gertler will explain the differences among U.S. investor classes and how to prepare your company for on point discussion. More info on Jonathan can be found here.
MODERATOR
Viveka Rydell-Andersen, Attorney and Healthcare Executive
DAY 2: The Future of Life Science
David Roberts, Senior Sales Executive at Captario
David will explain the drive to more personalized medicine and how AI and ML can help pharma minimize risk while going even faster. More info on David can be found here.
Asmen Gül, Co-Founder and CEO of Hela Technologies
Asmen will discuss the importance of patient-centric digital solutions and how he navigates a company from Sweden in the complex healthcare system of the United States. More info on Asmen can be found here.
Opening and closing remarks will be made by Cecilia Lif, Trade Counselor at the Embassy of Sweden in Washington, D.C. More info on Cecilia can be found here.
SPONSORS
HEAD SPONSOR
SPONSORS
Back Bay Life Science Advisors works with international Biopharma, Medtech Guidance and Investment Banking with Emphasis on US-Nordic Growth. The company was founded 12 years ago in Boston's Back Bay neighborhood by a physician with a long academic background and a life science advisor. Since then, Back Bay has become an integral part of the Boston and Nordic life science ecosystem with roots that run around the globe. With offices in Boston, Frankfurt and Toronto, Back Bay Life Science Advisors is a globally respected boutique consultancy known for pairing expert strategy with investment banking guidance and execution with a special emphasis on US-EU life sciences partnerships, particularly on the Nordic region. Back Bay has completed dozens of strategy and investment banking projects with Swedish, Danish and Norwegian organizations and provides supportive work for Nordic events throughout the year.
Back Bay works to advance biotech, healthtech and medtech development on an international level by partnering with life science innovators that range from global brands to emerging companies, nascent startups, government-backed incubators and academic centers. The Back Bay team, comprised of scientific researchers, biotech executives, physicians, surgeons, bankers and data researchers, excels at partnership and in guiding global life sciences companies and their investors through complex business, scientific, market and transactional challenges.
Back Bay is an industry leader for a reason; they know how to turn data into knowledge. With custom-designed due diligence, primary research, optimal strategy, forecasts and insight, Back Bay offers deeply experienced life science expertise. All of their assignments leverage a comprehensive range of data sources backed by the analytic capabilities of their team, and their integrated strategy and investment teams bring their scientific expertise, clinical knowledge and M&A experience to every project.
They provide solutions that are advantageous and actionable, and Back Bay delivers a keen understanding of the value of new technologies, medicines and scientific approaches. They work with companies across every stage, sector, geography and disease area to position assets for maximum value and impact.
Their strategic analytics have supported work by leading global banks and corporate entities, and Back Bay regularly works with clinicians, opinion leaders, investors, C-suite investors, payors and regulatory experts, across industry and academia.
Read more about Back Bay Life Science Advisors here.
